Lipopolysaccharide Downregulates Macrophage-derived IL-22 to Modulate Alcohol-induced Hepatocyte Cell Death

Overview

Journal Am J Physiol Cell Physiol

Publisher American Physiological Society

Specialties Cell Biology
Physiology

Date 2017 Jun 23

PMID 28637673

Citations 17

Authors

Yaming Liu

Vikas K Verma

Harmeet Malhi

Greg J Gores

Patrick S Kamath

Arun Sanyal

Naga Chalasani

Bin Gao

Vijay H Shah

Affiliations

Soon will be listed here.

Abstract

Interleukin-22 (IL-22) is a Th17 cell hepatoprotective cytokine that is undergoing clinical trials to treat patients with alcoholic hepatitis (AH). Lipopolysaccharide (LPS) activation of macrophage is implicated in hepatocyte cell death and pathogenesis of AH. The role of IL-22 production from macrophage, its regulation by LPS, and effects on alcohol-induced hepatocyte cell death are unexplored and were examined in this study. Low levels of IL-22 mRNA/protein were detected in macrophage but were significantly upregulated by 6.5-fold in response to the tissue reparative cytokine IL-10. Conversely, LPS significantly decreased IL-22 mRNA levels in a temporal and concentration-dependent manner with a maximum reduction of 5-fold. LPS downregulation of IL-22 mRNA levels was rescued in the presence of a pharmacological inhibitor of c-Jun NH-terminal kinase (JNK) and by JNK knockdown. Next, we explored whether macrophage-derived IL-22 regulated ethanol-induced hepatocyte death. Conditioned media from IL-10-stimulated macrophages attenuated ethanol-induced hepatocyte caspase-3/7 activity, and apoptosis as assessed by fluorometric assay and TdT-mediated dUTP nick-end labeling (TUNEL) staining, respectively. This effect was diminished in conditioned media from macrophages with IL-22 knockdown. Cytokine analysis in sera samples of patients with AH revealed that IL-22 levels were significantly elevated compared with healthy controls and heavy-drinking controls, implying a state of IL-22 resistance in human AH. Macrophage-derived IL-22 protects hepatocytes from ethanol-induced cell death. IL-22 downregulation is a new regulatory target of LPS in the pathogenesis of AH.

Citing Articles

Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease.

Abdelnabi M, Hassan G, Shoukry N Front Immunol. 2024; 15:1437046.

PMID: 39156888 PMC: 11327067. DOI: 10.3389/fimmu.2024.1437046.

Cirrhosis-Based Acute-on-Chronic Liver Failure Is Marked by Inflammation and Impaired Liver Regeneration Despite Stat3 Activation.

Lange C, Al-Juboori K, Rawitzer J, Moellmann D, Schlattjan M, Guckenbiehl S Gastro Hep Adv. 2024; 1(4):520-530.

PMID: 39132076 PMC: 11308700. DOI: 10.1016/j.gastha.2022.03.005.

IL-22, a vital cytokine in autoimmune diseases.

Li J, Wu Z, Wu Y, Hu X, Yang J, Zhu D Clin Exp Immunol. 2024; 218(3):242-263.

PMID: 38651179 PMC: 11557150. DOI: 10.1093/cei/uxae035.

Long non-coding RNA HOX transcript antisense intergenic RNA depletion protects against alcoholic hepatitis through the microRNA-148a-3p/sphingosine 1-phosphate receptor 1 axis.

Chen D, Lu P, Sun T, Ding A Cell Tissue Res. 2023; 394(3):471-485.

PMID: 37851113 DOI: 10.1007/s00441-023-03835-w.

Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions.

Yan Z, Chen B, Yang Y, Yi X, Wei M, Ecklu-Mensah G Nat Microbiol. 2022; 7(9):1361-1375.

PMID: 35995842 DOI: 10.1038/s41564-022-01196-8.

References

Ibiza S, Garcia-Cassani B, Ribeiro H, Carvalho T, Almeida L, Marques R . Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Nature. 2016; 535(7612):440-443. PMC: 4962913. DOI: 10.1038/nature18644. View

Wan J, Benkdane M, Teixeira-Clerc F, Bonnafous S, Louvet A, Lafdil F . M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology. 2013; 59(1):130-42. DOI: 10.1002/hep.26607. View

Bedoya S, Wilson T, Collins E, Lau K, Larkin 3rd J . Isolation and th17 differentiation of naïve CD4 T lymphocytes. J Vis Exp. 2013; (79):e50765. PMC: 3935776. DOI: 10.3791/50765. View

Verma V, Taneja V, Jaiswal A, Sharma S, Behera D, Sreenivas V . Prevalence, distribution and functional significance of the -237C to T polymorphism in the IL-12Rβ2 promoter in Indian tuberculosis patients. PLoS One. 2012; 7(4):e34355. PMC: 3317943. DOI: 10.1371/journal.pone.0034355. View

Manel N, Unutmaz D, Littman D . The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol. 2008; 9(6):641-9. PMC: 2597394. DOI: 10.1038/ni.1610. View

Cubero F, Zoubek M, Hu W, Peng J, Zhao G, Nevzorova Y . Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury. Gastroenterology. 2015; 150(4):968-81. PMC: 5285516. DOI: 10.1053/j.gastro.2015.12.019. View

Verma V, Li H, Wang R, Hirsova P, Mushref M, Liu Y . Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles. J Hepatol. 2015; 64(3):651-60. PMC: 4761285. DOI: 10.1016/j.jhep.2015.11.020. View

Dudakov J, Hanash A, van den Brink M . Interleukin-22: immunobiology and pathology. Annu Rev Immunol. 2015; 33:747-85. PMC: 4407497. DOI: 10.1146/annurev-immunol-032414-112123. View

Malhi H, Barreyro F, Isomoto H, Bronk S, Gores G . Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity. Gut. 2007; 56(8):1124-31. PMC: 1955518. DOI: 10.1136/gut.2006.118059. View

10.

Menon K, Gores G, Shah V . Pathogenesis, diagnosis, and treatment of alcoholic liver disease. Mayo Clin Proc. 2001; 76(10):1021-9. DOI: 10.4065/76.10.1021. View

11.

Mantovani A, Sozzani S, Locati M, Allavena P, Sica A . Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23(11):549-55. DOI: 10.1016/s1471-4906(02)02302-5. View

12.

Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T . The effect of inflammatory cytokines in alcoholic liver disease. Mediators Inflamm. 2014; 2013:495156. PMC: 3872233. DOI: 10.1155/2013/495156. View

13.

Ki S, Park O, Zheng M, Morales-Ibanez O, Kolls J, Bataller R . Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology. 2010; 52(4):1291-300. PMC: 2947578. DOI: 10.1002/hep.23837. View

14.

Rao R . Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology. 2009; 50(2):638-44. PMC: 6209509. DOI: 10.1002/hep.23009. View

15.

Boonstra A, Rajsbaum R, Holman M, Marques R, Asselin-Paturel C, Pereira J . Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J Immunol. 2006; 177(11):7551-8. DOI: 10.4049/jimmunol.177.11.7551. View

16.

Ju C, Mandrekar P . Macrophages and Alcohol-Related Liver Inflammation. Alcohol Res. 2016; 37(2):251-62. PMC: 4590621. View

17.

Witte E, Witte K, Warszawska K, Sabat R, Wolk K . Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev. 2010; 21(5):365-79. DOI: 10.1016/j.cytogfr.2010.08.002. View

18.

Hansson M, Silverpil E, Linden A, Glader P . Interleukin-22 produced by alveolar macrophages during activation of the innate immune response. Inflamm Res. 2013; 62(6):561-9. DOI: 10.1007/s00011-013-0608-1. View

19.

Weston C, Davis R . The JNK signal transduction pathway. Curr Opin Cell Biol. 2007; 19(2):142-9. DOI: 10.1016/j.ceb.2007.02.001. View

20.

Seo Y, Kwon J, Yaqoob U, Yang L, de Assuncao T, Simonetto D . HMGB1 recruits hepatic stellate cells and liver endothelial cells to sites of ethanol-induced parenchymal cell injury. Am J Physiol Gastrointest Liver Physiol. 2013; 305(11):G838-48. PMC: 3882432. DOI: 10.1152/ajpgi.00151.2013. View